KDR and neoplasm: VEGF can bind to vascular endothelial growth factor receptor 2 (VEGFR2) to mediate lymphatic and angiogenesis, participate in tumor angiogenesis and metastasis, and is closely related to the occurrence and development of SCLC tumors [19–22].